AGIO Stock Summary and Trading Ideas (Agios Pharmaceuticals | NASDAQ:AGIO)

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Agios Pharmaceuticals trades on the NASDAQ stock market under the symbol AGIO.

As of June 9, 2026, AGIO stock price climbed to $28.14 with 1,255,451 million shares trading.

AGIO has a beta of 2.43, meaning it tends to be more sensitive to market movements. AGIO has a correlation of 0.14 to the broad based SPY ETF.

AGIO has a market cap of $1.67 billion. This is considered a Small Cap stock.

Last quarter Agios Pharmaceuticals reported $21 million in Revenue and -$1.69 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.10.

In the last 3 years, AGIO traded as high as $62.58 and as low as $19.80.

The top ETF exchange traded funds that AGIO belongs to (by Net Assets): XBI, VTI, VB, IWM, VBK.

AGIO has underperformed the market in the last year with a return of -18.0%, while the SPY ETF gained +24.3%. In the last 3 month period, AGIO fell short of the market, returning +2.4%, while SPY returned +9.9%. However, in the most recent 2 weeks AGIO has outperformed the stock market by returning 0.0%, while SPY returned -1.2%.

AGIO support price is $26.53 and resistance is $28.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AGIO shares will trade within this expected range on the day.